Johnson & Johnson has settled with about 845 plaintiffs who filed suit over allegations that the company didn’t adequately warn them about the risks of tendon damage from an antibiotic called Levaquin.
According to Bloomberg, the settlements were disclosed in a filing from Minneapolis, where a federal judge is overseeing about 1,900 Levaquin lawsuits. The filing didn’t say how much the company will pay.
Overall, Johnson & Johnson faces more than 3,400 ...
continue reading...
Investment Website Seeking Alpha says that healthcare products giant Johnson & Johnson is poised to announce its third-quarter earnings report. The company is hoping to break a streak of revenue declines over the last two quarters, as well as net income declines over the past four quarters.
The report says Wall Street has a mixed view on the advisability of investing in the company. Goldman Sachs, for example, recently downgraded the ...
continue reading...
Participants in a recent government panel warn that computerized medical devices are increasingly susceptible to hacking, including infections by computer viruses.
According to a story in MIT’s Technology Review, the malware infections can clog patient-monitoring equipment and other software systems, at times rendering the devices temporarily inoperable.
The report quotes Kevin Fu, a leading expert on medical-device security and a computer scientist at the University of Michigan and the University of Massachusetts, ...
continue reading...
According to the Mayo Clinic, there are a number of risk factors for urinary incontinence.
Although urinary incontinence can be a distressing and inconvenient condition, it is treatable with options that include surgery, medication and physical therapy.
But some treatments, such as transvaginal mesh implants, can cause difficulties greater than the urinary incontinence itself.
The implants, marketed for treatment of urinary incontinence and pelvic organ prolapse, have prompted thousands of lawsuits due to ...
continue reading...
The Philadelphia Inquirer reports that an investigator employed by the state of Pennsylvania twice tried to warn that state employees were getting kick-backs from pharmaceutical companies.
Both times, according to the Inquirer, Pennsylvania state government officials dismissed Allen Jones and his information. In Texas, however, the attorney general used Jones’ information to obtain a $158 million payment from Johnson & Johnson’s Janssen subsidiary, manufacturer of the antipsychotic drug Risperdal.
The company offered ...
continue reading...
European Union officials are considering more stringent regulations for medical devices. But according to a report on MedPage Today, some European health advocates complain that the proposed regulations wouldn’t go far enough.
The report quotes Andrew Boulton, MD, president of the European Association for the Study of Diabetes, as saying: “We feel the proposals are a step in the right direction but we need many more steps to address patient safety.”
The ...
continue reading...
